| A9 | Mechanisms of residual immune activation in HIV-1 infected human lymphoid tissue ex vivo | On-demand oral abstract session | Systemic immune activation and inflammation |
| A9 | Novel multiplex analyses reveal disparate natural killer cell signaling pathway activation during lentivirus infection | On-demand oral abstract session | Systemic immune activation and inflammation |
| A9 | The circadian clock machinery regulates HIV transcription in CD4+ T cells | On-demand oral abstract session | Systemic immune activation and inflammation |
| A9 | Changes in inflammation scores among people living with HIV (PLWH) under different antiretroviral treatment (ART) regimes | E-poster | Systemic immune activation and inflammation |
| A9 | Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy | E-poster | Systemic immune activation and inflammation |
| A9 | Control of SIV replication in animals co-infected with M. tuberculosis does not eliminate high bacterial burden or dysregulated immunity present in SIV/Mtb co-infected animals | E-poster | Systemic immune activation and inflammation |
| A9 | Unique peripheral blood cell gene expression profiles in youth with long-term human immunodeficiency viral suppression | E-poster | Systemic immune activation and inflammation |
| A9 | Food insecurity is associated with increased immune activation in people living with HIV | E-poster | Systemic immune activation and inflammation |
| A9 | Transcriptome network analysis reveals the role of Tripterygium wilfordii hook F on interferon signaling pathway and immune activation in HIV immunological non-responders | E-poster | Systemic immune activation and inflammation |
| B10 | Single high-dose liposomal amphotericin based regimen for treatment of HIV-associated Cryptococcal Meningitis: results of the phase-3 Ambition-cm Randomised Trial | Oral abstract session with live Q&A | Opportunistic infections (excluding tuberculosis) |